GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
15.00
-0.11 (-0.74%)
Mar 17, 2026, 2:01 PM EDT - Market open
GH Research Employees
GH Research had 73 employees as of December 31, 2025. The number of employees increased by 23 or 46.00% compared to the previous year.
Employees
73
Change (1Y)
23
Growth (1Y)
46.00%
Revenue / Employee
n/a
Profits / Employee
-$661,068
Market Cap
930.29M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 73 | 23 | 46.00% |
| Dec 31, 2024 | 50 | 1 | 2.04% |
| Dec 31, 2023 | 49 | 17 | 53.13% |
| Dec 31, 2022 | 32 | 18 | 128.57% |
| Dec 31, 2021 | 14 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 700 |
| Xeris Biopharma Holdings | 435 |
| Pharming Group | 404 |
| UroGen Pharma | 291 |
| Xencor | 260 |
| uniQure | 221 |
| Sana Biotechnology | 142 |
| Adlai Nortye | 123 |
GHRS News
- 6 days ago - GH Research FY25 Results: Strong Cash Position As GH001 Advances Toward Phase 3 - Seeking Alpha
- 12 days ago - GH Research Reports Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - FDA Lifts Hold On GH Research's Depression Drug Trial After Two Years - Benzinga
- 2 months ago - GH Research Announces FDA Lifts Clinical Hold on GH001, Clearing Path for Global Phase 3 Initiation in 2026 - GlobeNewsWire
- 2 months ago - GH Research: GH001 Shows Robust Data Ahead Of FDA IND Decision - Seeking Alpha
- 2 months ago - GH Research to Announce IND Status for GH001 - GlobeNewsWire
- 4 months ago - GH Research Reports Third Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 5 months ago - Depression-Focused GH Research Shares Could See Significant Upside: Analyst - Benzinga